Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NOD-like receptor family pyrin domain containing 6 (NLRP6) inflammasome complex is a cytosolic multiprotein platform that plays a pivotal role in innate immunity and the maintenance of tissue homeostasis, particularly in the gastrointestinal tract [1, 6]. It is composed of the sensor protein NLRP6, the adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD), and the effector protease Caspase-1 or Caspase-11 [1, 13]. Upon activation by microbial components such as lipoteichoic acid (LTA) or viral double-stranded RNA (dsRNA), the complex assembles to facilitate the maturation and secretion of pro-inflammatory cytokines IL-1β and IL-18, as well as the induction of pyroptosis via gasdermin D cleavage [3, 7]. Beyond its inflammatory functions, the NLRP6 inflammasome is essential for regulating goblet cell mucus secretion and shaping the composition of the gut microbiota, thereby protecting against enteric pathogens and colitis [1, 8]. Dysregulation of this complex is associated with a variety of conditions, including inflammatory bowel disease (IBD), colorectal cancer, metabolic syndrome, and sepsis [5, 15]. While no specific NLRP6-targeted drugs are currently approved, the complex is an emerging therapeutic target; research is exploring small-molecule inhibitors, ASC-disrupting agents like IC 100, and the modulation of natural metabolites such as taurine and spermine to treat chronic inflammatory and metabolic diseases [14, 16].
Inhibition of inflammasome assembly, disruption of ASC speck formation, and modulation of caspase-1/11 activation to prevent the release of pro-inflammatory cytokines IL-1β and IL-18 [1, 16].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NOD-like receptor family pyrin domain containing 6 inflammasome complex (NLRP6 inflammasome).